Lack of prior screening for advanced liver fibrosis in patients with newly diagnosed hepatocellular carcinoma: Results from a prospective multicentre study
Recognition by general practitioners of patients at risk of chronic liver disease and identification of advanced fibrosis are major areas for optimization of HCC screening.
Authors
- Maëva Salimon
- Matthieu Schnee (ORCID: https://orcid.org/0000-0001-6152-405X)
- Paul Girot
- Sylvie Métairie (ORCID: https://orcid.org/0000-0003-0527-4986)
- Carelle Koudougou
- Yann Touchefeu (ORCID: https://orcid.org/0000-0001-8421-3182)
- Nour Ben Yedder
- Annie Lim
- Kouceila Soualah
- Samuel Andrault
Institutions
- Inserm (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Centre Hospitalier de Lens (FR)
- Institut Génétique Nantes Atlantique (FR)
- Centre d'Investigation Clinique de Nantes (FR)
- Centre Hospitalier Départemental Vendée (FR)
- Centre Hospitalier Henri Laborit (FR)
- Clinique Jules Verne (FR)
- Nantes Université (FR)
Publication Details
- Journal
- Clinics and Research in Hepatology and Gastroenterology
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.clinre.2025.102607
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00